drugset / Trial / NCT05731050
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NaSequentialOpen-labelTreatment
Summary
The proposed study, NM8074-PNH-101, is a phase II, open-label, multi-dose, unicenter trial to evaluate the safety and efficacy of NM8074 in Soliris-treated PNH subjects.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-09
- Completion
- 2028-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RUXOPRUBART | Monoclonal antibody | 15 mg/kg | Intravenous |